Literature DB >> 17502718

Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel.

Vincent Soriano1, Massimo Puoti, Mark Sulkowski, Antonietta Cargnel, Yves Benhamou, Marion Peters, Stefan Mauss, Norbert Bräu, Angelos Hatzakis, Stanislas Pol, Juergen Rockstroh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17502718     DOI： 10.1097/QAD.0b013e3281084e4d

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  72 in total

Review 1.  The management of chronic hepatitis B in Asian Americans.

Authors:  Myron J Tong; Calvin Q Pan; Hie-Won Hann; Kris V Kowdley; Steven-Huy B Han; Albert D Min; Truong-Sinh Leduc
Journal:  Dig Dis Sci       Date:  2011-09-21       Impact factor: 3.199

2.  Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.

Authors:  Jaimie P Meyer; Javier Cepeda; Johnny Wu; Robert L Trestman; Frederick L Altice; Sandra A Springer
Journal:  JAMA Intern Med       Date:  2014-05       Impact factor: 21.873

3.  Infectious disease comorbidities adversely affecting substance users with HIV: hepatitis C and tuberculosis.

Authors:  Gerald Friedland
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

Review 4.  Hepatitis infection in the treatment of opioid dependence and abuse.

Authors:  Thomas F Kresina; Diana Sylvestre; Leonard Seeff; Alain H Litwin; Kenneth Hoffman; Robert Lubran; H Westley Clark
Journal:  Subst Abuse       Date:  2008-04-28

5.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

6.  [Not Available].

Authors:  Mark Hull; Pierre Giguère; Marina Klein; Stephen Shafran; Alice Tseng; Pierre Côté; Marc Poliquin; Curtis Cooper
Journal:  Can J Infect Dis Med Microbiol       Date:  2014       Impact factor: 2.471

7.  Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients.

Authors:  Norma I Rallón; Susanna Naggie; José M Benito; José Medrano; Clara Restrepo; David Goldstein; Kevin V Shianna; Eugenia Vispo; Alex Thompson; John McHutchison; Vincent Soriano
Journal:  AIDS       Date:  2010-05-15       Impact factor: 4.177

8.  Adherence to hepatitis C virus therapy in HIV/hepatitis C-coinfected patients.

Authors:  Vincent Lo Re; Valerie Teal; A Russell Localio; Valerianna K Amorosa; David E Kaplan; Robert Gross
Journal:  AIDS Behav       Date:  2013-01

9.  Uncommon hepatitis B virus and/or hepatitis C virus occult infection in HIV-positive patients with abnormal level of hepatic enzyme.

Authors:  Natalia Laufer; Lucila Cassino; Federico Bolcic; Franco Moretti; Rita Reynoso; Maria Belen Bouzas; Pedro Cahn; Horacio Salomón; Jorge Quarleri
Journal:  J Acquir Immune Defic Syndr       Date:  2008-10-01       Impact factor: 3.731

10.  Abacavir does not influence the rate of virological response in HIV-HCV-coinfected patients treated with pegylated interferon and weight-adjusted ribavirin.

Authors:  Natalia Laufer; Montserrat Laguno; Iñaki Perez; Carmen Cifuentes; Javier Murillas; Francesc Vidal; Lucia Bonet; Sergio Veloso; José María Gatell; Josep Mallolas
Journal:  Antivir Ther       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.